CTI BIOPHARMA CORP - COM (CTIC)

CUSIP: 12648L601

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM
Total 13F shares
6,673,934
Share change
+6,285,378
Total reported value
$28,030,084
Price per share
$4.20
Number of holders
35
Value change
+$26,966,855
Number of buys
32
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 12648L601?
CUSIP 12648L601 identifies CTIC - CTI BIOPHARMA CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CTI BIOPHARMA CORP - COM (CTIC) as of Q1 2017

As of 31 Mar 2017, CTI BIOPHARMA CORP - COM (CTIC) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,673,934 shares. The largest 10 holders included BVF INC/IL, VANGUARD GROUP INC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, JANE STREET GROUP, LLC, UNITED CAPITAL FINANCIAL ADVISERS, LLC, and GOLDMAN SACHS GROUP INC. This page lists 35 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.